Soleno Therapeutics, Inc.

SLNO US8342033094

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

Annual Performance ¹

2021	2022	2023	2024	2025
-80%	-70%	1738%	18%	2%

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Hirano Patricia C O	82.76 USD	3,830 Sold	316,971 USD	01/07/2025	01/07/2025
Hirano Patricia C O	84.25 USD	266 Sold	22,411 USD	24/06/2025	24/06/2025
Hirano Patricia C O	70.11 USD	3,782 Sold	265,156 USD	01/04/2025	01/04/2025
Hirano Patricia C O	67.46 USD	3,394 Sold	228,946 USD	27/03/2025	28/03/2025
Hirano Patricia C O	68.92 USD	12,324 Sold	849,386 USD	27/03/2025	28/03/2025
Hirano Patricia C O	69.52 USD	9,253 Sold	643,246 USD	27/03/2025	28/03/2025
Hirano Patricia C O	73.60 USD	2,691 Sold	198,058 USD	27/03/2025	28/03/2025
Pauls Matthew O	71.55 USD	5,937 Sold	424,797 USD	28/03/2025	28/03/2025
Hirano Patricia C O	70.18 USD	24,989 Sold	1,753,628 USD	27/03/2025	27/03/2025
Anish Bhatnagar CEO	70.73 USD	3,291 Sold	232,786 USD	27/03/2025	27/03/2025

Load More

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Soleno Therapeutics, Inc. to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Historical Performance

1M	3M	6M	1Y	3Y	5Y	All Time
-12%	-0%	6%	980%	72%	5%	-67%

Last	52W Low	52W High	All-Time Low	All-Time High	β
58.45	42.54	88.49	0.89	138.75

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Anish Bhatnagar	39	67,871,594.43	1,740,297.29	28/11/2023	27/03/2025
Hirano Patricia C	45	13,389,543.82	297,545.42	28/11/2023	01/07/2025
Mackaness James H	39	11,125,108.38	285,259.19	28/11/2023	27/03/2025
Yen Kristen	37	9,698,352.02	262,117.62	28/11/2023	27/03/2025
Manning Meredith	9	3,044,342.88	338,260.32	27/03/2025	27/03/2025
Huang Michael F.	9	1,013,627.06	112,625.23	27/03/2025	27/03/2025
Pauls Matthew	1	424,797.10	424,797.10	28/03/2025	28/03/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies ³

Name	ISIN	Ticker
SAVARA INC.	US8051111016	SVRA

³ the firms where the current insiders have executed transactions.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.